- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Erythrodermic cutaneous T-cell lymphoma
- Meeting Date: May 2020
- Public Summary Document (PSD) May 2020 PBAC Meeting - (PDF 831KB)
- Public Summary Document (PSD) May 2020 PBAC Meeting - (Word 167KB)
Methoxsalen – May 2020
Methoxsalen: Solution for blood fraction, 20 microgram per mL, 10 mL; Uvadex®
Last updated
28 August 2020